Cord blood DNA methylation and cell type composition are not significantly associated with severe preeclampsia, after cell type and clinical covariate adjustment
GigaScience · 21.01.2026 · 15
DOI: 10.1093/gigascience/giag002 ↗Kurz gefasst
Fachartikel in der Zeitschrift GigaScience, online erschienen am 16.01.2026. Verfasst von Xiaotong Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Pre-Eclampsia, DNA Methylation, Fetal Blood. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, NLM NIH HHS.
Abstract (Originalsprache)
Background
Preeclampsia is a severe pregnancy complication that threatens maternal and neonatal health and well-being. Previous studies on epigenome-wide association analysis (EWAS) of preeclampsia produced inconsistent results in cord blood tissues, and one possible explanation is their failure to rigorously adjust for cell proportions, gestational age, or other necessary variables.
Methods
Here, we calculated the DNA methylation change in cord blood from newborns affected by preeclampsia, using a multi-ethnic cohort from the Hawaii population (24 cases, 38 controls). We comprehensively adjusted for variables such as maternal age, body mass index (BMI), parity, and estimated the cell proportions. We also re-analyzed two previous datasets with adjustments to estimated cell proportions and conducted a pooled analysis by merging all three datasets together to increase the statistical power (58 cases, 71 controls). Lastly, we include idiopathic preterm (preterm delivery with no known reasons) cord blood samples (n=11) to disentangle the effect of severe preeclampsia and small gestational age.
Results
We showed that after adjusting cell type proportions and patient clinical characteristics, most of the so-called statistically significant CpG methylation changes associated with severe preeclampsia disappeared in our own data, two public datasets, and the pooled analysis combining all three datasets. This result still holds after including idiopathic preterm samples in the control group. Rather, we found that gestation progression is accompanied by statistically significant proportion changes in several cell types, such as granulocytes, nRBCs, CD8Ts, and B cells, which contribute to most DNA methylation differences between case and control groups. Preeclampsia has interactions on cell proportion changes in granulocytes, monocytes, and nRBCs.
Conclusions
In summary, our study shows that the previously reported differentially methylated patterns in cord blood are actually artifacts due to not properly adjusting for cell type heterogeneity, gestational age, and clinical covariates. Severe preeclampsia is not associated with statistically significant DNA methylation changes but changes in cell proportion. This finding alerts to the scientific rigor needed in EWAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
- Epidemiology, University of Hawaii Cancer Center, Honolulu, HI 96813, USA.
- Department of Internal Medicine, Nephrology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii, Honolulu, HI 96826, USA.
ORCID-Profile: Xiaotong Yang, Wenting Liu, Zhixin Mao, Yuheng Du, Cameron Lassiter, Fadhl M Alakwaa, Paula A Benny, Lana X Garmire
Förderung
- NICHD NIH HHS
- NIH HHS
- NLM NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Yang, X., Liu, W., Mao, Z., Du, Y., Lassiter, C., Alakwaa, F. M., Benny, P. A., & Garmire, L. X. (2026). Cord blood DNA methylation and cell type composition are not significantly associated with severe preeclampsia, after cell type and clinical covariate adjustment. GigaScience, 15. https://doi.org/10.1093/gigascience/giag002
Vancouver
Yang X, Liu W, Mao Z, Du Y, Lassiter C, Alakwaa FM, et al. Cord blood DNA methylation and cell type composition are not significantly associated with severe preeclampsia, after cell type and clinical covariate adjustment. GigaScience. 2026;15. doi:10.1093/gigascience/giag002
BibTeX
@article{Yang2026,
author = {Yang, Xiaotong and Liu, Wenting and Mao, Zhixin and Du, Yuheng and Lassiter, Cameron and Alakwaa, Fadhl M and Benny, Paula A and Garmire, Lana X},
title = {Cord blood DNA methylation and cell type composition are not significantly associated with severe preeclampsia, after cell type and clinical covariate adjustment},
journal = {GigaScience},
year = {2026},
volume = {15},
doi = {10.1093/gigascience/giag002}
}
EUVIMED